RE: Shenanigans9 Jul 2021 10:43
The govt's gamble on the vaccine programme has paid off. They're happy that deaths will fall to a sustainable level, I personally think this is currently a risk too far due to Delta but time will tell. At the time the £8bn DPS was published it was still looking like testing was the only way to control the virus. The govt have reverted to testing being a longer term need for monitoring and ensuring the safety of schools, hospitals, test and trace etc whilst putting responsibility on businesses for their employees. Responsible companies will look at test their employees regularly.
Where does that leave us in the UK? It depends on how much fluff is behind the intention to build a diagnostics capability and use it. If the machines are installed then as the best test, we're well positioned to a key part of that via GAD at least. Looks like Orient Gene for now, but will this continue further down the road as the capability comes online. For the private sector, we have the best of british and a world beater at a competitive price. The opportunity remains, but it won't be an overnight success. That's where we are. I believe the drop has been overdone, especially considering the conservative broker's valuation.
Meanwhile, you have the rest of the globe still needing an awful lot of testing as their vaccine programmes are miles behind. Again, via GAD, we can sell to these LMICs. Best not discount the opportunity elsewhere for Travel where 100/100 for the infectious is very important. I agree with RD, negotiations will be continuing.